> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# New Research on Unapproved Use of Approved Drugs
- URL: https://www.fdaweb.com/new-research-on-unapproved-use-of-approved-drugs/
- Published: 2021-06-11T12:00:00.000Z
- Updated: 2026-09-14T17:03:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149518

*Federal Register* notice: FDA has submitted to OMB an information collection entitled “Study of Disclosures to Healthcare Providers Regarding Data That Do Not Support Unapproved Use of an Approved Prescription Drug.” The new research is intended to examine physicians’ perceptions and behavioral intentions about an unapproved new use of an approved prescription drug when made aware of other data that are not supportive of the unapproved use. This research will also evaluate the effectiveness of various disclosure approaches for communicating the unsupportive information. FDA says research results should provide a better understanding of physicians’ perceptions of an unapproved use of a prescription drug, and their perceptions about an unapproved use of an approved prescription drug when they are aware of the existence of unsupportive information about it. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-06-11/pdf/2021-12265.pdf?ref=fdaweb.com).